Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells

Journal of Immunology

Volumn 167, Issue 11, 2001, Pages 6462-6470

  Chikh, G G ^a   Kong, S ^a   Bally, M B ^a   Meunier, J C ^a   Schutze Redelmeier, M P M ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTENNAPEDIA PROTEIN; CANCER VACCINE; CD8 ANTIGEN; DODECYL SULFATE SODIUM; EPITOPE; HYBRID PROTEIN; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEIN ANTPHD CW3; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; EPITOPE MAPPING; GENE FUSION; IMMUNOGENICITY; IMMUNOSTIMULATION; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE ACTIVATION;

EID: 0035575703     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.11.6462     Document Type: Article

References (59)

1. Induction of CTLs and antitumor immunity with DNA vaccines expressing single T cell epitopes
2. Vaccine therapy for prostate cancer
3. Overview of melanoma vaccines: Active specific immunotherapy for melanoma patients
4. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
5. Tumor antigens recognized by T cells
6. Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
7. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
8. Dendritic cell-based vaccine: A promising approach for cancer immunotherapy
9. The dendritic cell and human cancer vaccines
10. + T cell response to repetitive stimulation with APCs in vitro: Implications in designing APC-based tumor vaccines
11. Liposomes as carriers of cancer chemotherapy. Current status and future prospects
12. Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice
13. An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicin
14. Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen
15. + cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation
16. Liposomal formulations of synthetic MUC1 peptides: Effects of encapsulation versus surface display of peptides on immune responses
17. Liposomes as carriers of peptide antigens: Induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides
18. Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS, S malaria antigen
19. pH sensitive liposomes provide an efficient means of sensitizing target cells to class 1 restricted Ctl recognition of a soluble protein
20. Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: A model study
21. In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes
22. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class 1 processing pathway
23. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose
24. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins
25. Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes
26. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo
27. Restriction of self-antigen presentation to cytolytic T lymphocytes by mouse peptide pumps
28. Rab3A and Rab3B carboxy-terminal peptides are both potent and specific inhibitors of prolactin release by rat cultured anterior pituitary cells
29. Production of large unilamellar vesicles by a rapid extrusion procedure: Characterization of size distribution, trapped volume and ability to maintain a membrane potential
30. Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages
31. Pharmacodynamics of liposomal drug carriers: Methodological considerations
32. Vesicles of variable sizes produced by a rapid extrusion procedure
33. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
34. Alloantigen pretreatment induces a down-regulation of the in vivo subsequent development of cytotoxic T lymphocytes directed against linked alloantigens
35. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
36. Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes
37. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
38. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes
39. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells
40. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1
41. CpG-DNA activates in vivo T cell epitope-presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses
42. Characterization of an in situ IFN-γ ELISA which is able to detect specific peptide responses from freshly isolated splenocytes induced by DNA minigene immunization
43. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope
44. The B subunit of shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens
45. In vivo protein transduction: Delivery of a biologically active protein into the mouse
46. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration
47. Antennapedia homeobox peptide regulates neural morphogenesis
48. In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and antitumour immunity
49. Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing
50. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope
51. Proteasomes can either generate or destroy MHC class I epitopes: Evidence for nonproteasomal epitope generation in the cytosol
52. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
53. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules
54. Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposomal lipid and liposomal protein
55. + T cells requires secretion of hemolysin and intracellular bacterial growth
56. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent
57. Poly(ethylene glycol) derivative of cholesterol reduces binding step of liposome uptake by murine macrophage-like cell line J774 and human hepatoma cell line HepG2
58. Cationic liposome-plasmid DNA complexes used for gene transfer retain a significant trapped volume
59. Homeodomain proteins